Asset sale Announced
Cheplapharm acquisition of portfolio of 20 mature medicines and three manufacturing sites
Announced Sep 2026
Advisers
portfolio of 20 mature medicines and three manufacturing sites
Target
- Legal adviser
Cheplapharm
Acquirer
- Legal adviser
- Target
- portfolio of 20 mature medicines and three manufacturing sites
- Acquirer
- Cheplapharm
- Seller
- Sanofi
- Buyer based in
- Germany
- Seller based in
- France
- Sector
- Pharma
- Tags
- Pharma, Pharmaceutical Manufacturing
Similar deals
- Aurobindo acquisition of Lannett Jul 2026 · US$250m · Pharma
- Rovi acquisition of Manufacturing facility in Phoenix, AZ Mar 2026 · Pharmaceutical Manufacturing
- PAI Pharma acquisition of Nivagen Pharmaceuticals Jan 2026 · Pharmaceutical Manufacturing
- ACS Dobfar acquisition of Istituto Biochimico Italiano Giovanni Lorenzini (IBI Lorenzini) 2026 · Pharmaceutical Manufacturing
- GTCR acquisition of Zentiva Sep 2025 · Pharma
Sources
- Sep 2026 Latham Advises Cheplapharm on Strategic Partnership With Sanofi lw.com
- 18 Sep 2026 Freshfields advises Sanofi on its strategic partnership with Cheplapharm freshfields.com
